Jenburkt Pharmaceuticals P/B Ratio
Jenburkt Pharmaceuticals (JENBURPH) P/B ratio is 2.59 (Moderate), book value per share ₹430.00 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. View JENBURPH 52-week chart for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
JENBURPH P/B Ratio — Valuation Insights & Book Value Analysis
Jenburkt Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 2.59 (Moderate). For live price, earnings yield and the full fundamental profile, see Jenburkt Pharmaceuticals share price screener.
- Trading at premium to sector average PB of -0.33
Jenburkt Pharmaceuticals P/B Ratio Historical Trend
JENBURPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with JENBURPH DCF valuation to assess whether the stock is under or overvalued.
JENBURPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Jenburkt Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 2.53 | ₹430.0 | ₹1089.80 | ₹172 | Moderate |
| 2024 | 3.35 | ₹362.5 | ₹1214.70 | ₹145 | High |
| 2023 | 2.23 | ₹305.0 | ₹680.15 | ₹122 | Moderate |
| 2022 | 2.78 | ₹234.0 | ₹650.00 | ₹117 | Moderate |
| 2021 | 2.69 | ₹198.0 | ₹533.00 | ₹99 | Moderate |
JENBURPH vs Healthcare Peers — P/B Ratio Comparison
Jenburkt Pharmaceuticals P/B 2.59 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |